Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs.

Saved in:
Bibliographic Details
Title: Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs.
Authors: González-Gay MÁ; Rheumatology Division, IIS-Fundación Jiménez Díaz, Madrid, Spain.; Department of Medicine and Psychiatry, University of Cantabria, Santander, Spain., Álvarez-Rubio M; Rheumatology Division, IIS-Fundación Jiménez Díaz, Madrid, Spain., de Benito-Vernière A; Rheumatology Division, IIS-Fundación Jiménez Díaz, Madrid, Spain., Belhaj-Gandar M; Rheumatology Division, IIS-Fundación Jiménez Díaz, Madrid, Spain., Roca-Magnet M; Rheumatology Division, IIS-Fundación Jiménez Díaz, Madrid, Spain., Vicente-Rabaneda EF; Rheumatology Division, Hospital Univ. de La Princesa, IIS-Princesa, Madrid, Spain.; Department of Medicine, Autonomous University of Madrid, Madrid, Spain., Castañeda S; Rheumatology Division, Hospital Univ. de La Princesa, IIS-Princesa, Madrid, Spain.
Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 May; Vol. 27 (7), pp. 611-623. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article; Review
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1744-7666
DOI:10.1080/14656566.2026.2668585